1.68
price up icon2.44%   0.04
after-market Dopo l'orario di chiusura: 1.68
loading
Precedente Chiudi:
$1.64
Aprire:
$1.63
Volume 24 ore:
530.81K
Relative Volume:
0.63
Capitalizzazione di mercato:
$103.13M
Reddito:
$5.03M
Utile/perdita netta:
$-185.41M
Rapporto P/E:
-0.5437
EPS:
-3.09
Flusso di cassa netto:
$-139.79M
1 W Prestazione:
-7.18%
1M Prestazione:
+13.51%
6M Prestazione:
+5.66%
1 anno Prestazione:
-88.06%
Intervallo 1D:
Value
$1.61
$1.73
Intervallo di 1 settimana:
Value
$1.61
$1.95
Portata 52W:
Value
$1.1001
$16.10

Pliant Therapeutics Inc Stock (PLRX) Company Profile

Name
Nome
Pliant Therapeutics Inc
Name
Telefono
650-481-6770
Name
Indirizzo
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Name
Dipendente
171
Name
Cinguettio
Name
Prossima data di guadagno
2024-11-07
Name
Ultimi documenti SEC
Name
PLRX's Discussions on Twitter

Confronta PLRX con altri titoli

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
Biotechnology icon
PLRX
Pliant Therapeutics Inc
1.68 100.68M 5.03M -185.41M -139.79M -3.09
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.57 107.66B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
651.80 68.74B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
456.04 58.93B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
818.50 50.51B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
189.60 41.29B 447.02M -1.18B -868.57M -6.1812

Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades

Data Azione Analista Modifica della valutazione
2025-10-10 Downgrade JP Morgan Neutral → Underweight
2025-03-04 Ripresa Cantor Fitzgerald Neutral
2025-03-04 Downgrade Needham Buy → Hold
2025-03-03 Downgrade Leerink Partners Outperform → Market Perform
2025-03-03 Downgrade Stifel Buy → Hold
2025-02-10 Downgrade Canaccord Genuity Buy → Hold
2025-02-10 Downgrade Citigroup Buy → Neutral
2025-02-10 Downgrade H.C. Wainwright Buy → Neutral
2025-02-10 Downgrade JP Morgan Overweight → Neutral
2025-02-10 Downgrade Oppenheimer Outperform → Perform
2025-02-10 Downgrade RBC Capital Mkts Outperform → Sector Perform
2025-02-10 Downgrade Wells Fargo Overweight → Equal Weight
2024-09-09 Ripresa Leerink Partners Outperform
2023-12-08 Iniziato Wells Fargo Overweight
2023-05-18 Iniziato Canaccord Genuity Buy
2023-04-13 Iniziato Robert W. Baird Outperform
2022-12-14 Iniziato Stifel Buy
2022-12-07 Iniziato JP Morgan Overweight
2022-09-01 Iniziato Citigroup Buy
2022-07-20 Iniziato SVB Leerink Outperform
2022-05-25 Iniziato Cantor Fitzgerald Overweight
2021-12-10 Iniziato Oppenheimer Outperform
2021-11-24 Iniziato RBC Capital Mkts Outperform
2021-11-03 Iniziato H.C. Wainwright Buy
2021-04-20 Iniziato BTIG Research Buy
2021-04-05 Iniziato Citigroup Buy
2020-06-29 Iniziato Citigroup Buy
2020-06-29 Iniziato Cowen Outperform
2020-06-29 Iniziato Needham Buy
2020-06-29 Iniziato Piper Sandler Overweight
Mostra tutto

Pliant Therapeutics Inc Borsa (PLRX) Ultime notizie

pulisher
Nov 02, 2025

Heatmap analysis for Pliant Therapeutics Inc. and competitorsMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Chart overlay techniques for tracking Pliant Therapeutics Inc.July 2025 Update & Fast Entry High Yield Tips - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Does Pliant Therapeutics Inc. show high probability of reboundMarket Performance Summary & Verified Chart Pattern Signals - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Is Pliant Therapeutics Inc. stock cheap at current valuationShare Buyback & Precise Trade Entry Recommendations - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Why Pliant Therapeutics Inc. stock is favored by top institutionsIndex Update & Weekly High Momentum Picks - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Analyzing recovery setups for Pliant Therapeutics Inc. investorsOptions Play & Weekly Chart Analysis and Guides - newser.com

Nov 02, 2025
pulisher
Nov 01, 2025

Will Pliant Therapeutics Inc. stock deliver shareholder valueTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

What indicators show strength in Pliant Therapeutics Inc.2025 Geopolitical Influence & Fast Entry Momentum Alerts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Will Pliant Therapeutics Inc. (9PT) stock outperform global peersMarket Rally & Reliable Breakout Forecasts - newser.com

Nov 01, 2025
pulisher
Nov 01, 2025

Can Pliant Therapeutics Inc. (9PT) stock double in coming yearsJuly 2025 Review & Weekly Stock Performance Updates - newser.com

Nov 01, 2025
pulisher
Oct 31, 2025

Technical signs of recovery in Pliant Therapeutics Inc.Jobs Report & Weekly Breakout Opportunity Watchlist - newser.com

Oct 31, 2025
pulisher
Oct 31, 2025

Price momentum metrics for Pliant Therapeutics Inc. explained2025 Institutional Moves & Accurate Entry/Exit Alerts - newser.com

Oct 31, 2025
pulisher
Oct 30, 2025

Pliant Therapeutics (PLRX) Expected to Announce Earnings on Thursday - MarketBeat

Oct 30, 2025
pulisher
Oct 30, 2025

Can Pliant Therapeutics Inc. stock maintain operating marginsJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com

Oct 30, 2025
pulisher
Oct 28, 2025

Is Pliant Therapeutics Inc. (9PT) stock worth buying before Fed actionWeekly Loss Report & Fast Momentum Stock Entry Tips - fcp.pa.gov.br

Oct 28, 2025
pulisher
Oct 27, 2025

Will Pliant Therapeutics Inc. stock gain from strong economy2025 Dividend Review & Real-Time Buy Signal Notifications - fcp.pa.gov.br

Oct 27, 2025

Pliant Therapeutics Inc Azioni (PLRX) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$37.54
price up icon 1.62%
$93.48
price up icon 0.96%
$28.61
price down icon 0.21%
$103.91
price down icon 0.73%
biotechnology ONC
$310.48
price up icon 0.73%
$189.60
price down icon 2.38%
Capitalizzazione:     |  Volume (24 ore):